Webinars, Pharmaceutical

Drug Delivery Systems & Services for Lifecycle Management of Crisis Medications and Beyond

The opportunities associated with nasal drug repurposing are not to be sniffed at. This webinar uses case studies to illustrate the potential including the example of repurposing an existing lifesaving therapy to ease administration in an emergency situation. It explains how to accelerate and de-risk programs including those associated with the development of therapeutics and vaccines for COVID-19; in today’s fast changing global pandemic, drug repurposing can save lives. Drug repurposing also presents other benefits for lifecycle management including, but not limited to, intellectual property creation and increased market share, access to faster, less complex regulatory pathways, patient empowerment, and less reliance on healthcare practitioners. The need to consider human factors and the selection of the right regulatory pathway are highlighted with respect to ensuring project success. The benefits of customization and connected add-ons for differentiation and improved patient outcomes are also discussed.

May 12, 2020 5:00 PM London / 12:00 PM New York 1 Hour
Watch the webinar
Presented by Guillaume Brouet Dr. Julie D. Suman
12 May 2020

Presented By

Guillaume Brouet

Vice-President - Analytical, Regulatory and Scientific Affairs, Aptar Pharma

Guillaume Brouet is Vice-President, Analytical, Regulatory and Scientific Affairs for Aptar Pharma. He

has 25 years of experience in the development and qualification of drug delivery systems as well as analytical and formulation development. He has spoken previously at multiple respiratory and nasal drug delivery conferences. Mr. Brouet graduated from Ecole Supérieure de Chimie Organique et Minérale (ESCOM, Paris, France) and earned an Msc in Physical Chemistry, which he obtained at the University of Houston, TX, US.

Dr. Julie D. Suman

PhD, President, Next Breath, an Aptar Pharma Company

Julie holds a B.S. in Pharmacy from Duquesne University (1996) and a Ph.D. in Pharmaceutical Sciences from the University of Maryland, Baltimore (2002). She is a co-editor for Respiratory Drug Delivery Proceedings, an international symposium, and an Affiliate Assistant Professor in the Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University. Julie is a Past-Chair of the AAPS Inhalation Technology Focus Group. She is also a licensed Maryland pharmacist. Julie has published her research in peer-reviewed journals, has presented during podium sessions at international meetings such as the FDA Visiting Professor Lecture Series, and has been an invited speaker at ANVISA in Brazil. Dr. Suman’s doctoral research, which focused on the relationship between in vitro tests for nasal sprays and in vivo deposition, has been recognized for excellence by a research award presented at the International Society for Aerosols in Medicine, 2001.

Start a Project With Us

We Thrive on Transforming Ideas into Opportunities – Let Yours be Next.

Contact a Pharma Expert

Request Access


Requesting access to Drug Delivery Systems & Services for Lifecycle Management of Crisis Medications and Beyond.

  • This field is for validation purposes and should be left unchanged.
Back To Top